Trials / Sponsors / Mainline Biosciences, Inc.
Mainline Biosciences, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer | EARLY_Phase 1 | 2022-12-01 |